http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112546051-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d84aa8c4818bda002eded1de6d318389 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate | 2020-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23a5cb90afde042a0e923f4717c7e0e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0a869190d765db8df78faba607ef517 |
| publicationDate | 2021-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112546051-A |
| titleOfInvention | Application of compound |
| abstract | The invention provides application of a compound for enhancing the activity of gamma secretase in vitro, wherein the compound is N- [4- [ [ (3-methoxypyrazinyl) amino ] sulfonyl ] phenyl ] -3- (5-nitro-2-thienyl) -2-acrylamide, and the structural formula of the compound is shown as a formula (I). The compound can obviously enhance the activity of gamma secretase in an in-vitro cell model, thereby reducing the difficulty of detecting and analyzing the gamma secretase and providing good conditions for subsequent large-scale drug screening work taking the gamma secretase as a target. |
| priorityDate | 2020-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.